All posts by imreal

Beverly Hills Non-Surgical Aesthetic Cosmetic Specialist, Sam Assassa, M.D., is Recognized as a 2023 Top Patient Rated Doctor


More about Dr. Sam Assassa:

Sam Assassa, M.D. is a world-renowned non-surgical aesthetic cosmetic specialist. In 1995, he founded Beverly Hills Aesthetics, a cosmetic surgery center providing clients with non-surgical and laser services in the comfort of his state-of-the-art facility. Dr. Assassa received his medical degree with honors and completed his internship at Loyola University-affiliated hospitals in Chicago and residency at Case Western University-affiliated hospitals in Cleveland. He has extensive experience in minimally invasive non-surgical aesthetic procedures and other groundbreaking techniques. He was one of the first cosmetic surgeons on the West Coast to introduce the CosmoFaceLift™ procedure, also called the “One-Hour Non-Surgical Facelift,” and Smart Liposculpt™ for the face and body. Beverly Hills Aesthetics is located at 640 South San Vicente Blvd Suite #410 in Los Angeles, CA. To schedule a consultation or for more information, please call 424-292-2867 or visit http://www.bhaesthetics.com.

Media Contact

Dr. Sam Assassa, Beverly Hills Aesthetics, 424-292-2867, [email protected], https://www.bhaesthetics.com/

SOURCE Beverly Hills Aesthetics

IV DRIPS Customized IV Hydration & Wellness Now Offering Sacramento, CA, Residents Premier Mobile Intravenous Therapy Service



IV DRIPS is excited to provide concierge, on-demand in-home drips, hydration drips, hangover drips, immunity drips and more to clients in Sacramento.

SACRAMENTO, Calif., Dec. 4, 2023 /PRNewswire-PRWeb/ — IV DRIPS Customized IV Hydration & Wellness is thrilled to announce its expansion into the Sacramento area. With a mission to enhance health and well-being, IV DRIPS is now offering concierge, on-demand, in-home drips to clients in Sacramento and its surrounding areas. This premier mobile IV therapy service provides clients with proprietary IV infusion blends that are loaded with essential fluids, electrolytes, vitamins and antioxidants designed to promote whole-body health. Everyone has experienced days when they do not feel their best. Whether the flu or a few too many cocktails the night before are affecting well-being, there is no reason to suffer. IV DRIPS’ expansion into Sacramento comes at a time when the demand for mobile wellness services is on the rise. The convenience and effectiveness of IV hydration therapy have gained popularity among individuals seeking quick and efficient solutions to their health concerns. Delivering hydration & nutrients via IV means clients get 100% absorption of these essential elements delivered directly to the cells through the bloodstream. Depending on the desired result, IV DRIPS has several different customizable IV drip formulas to choose from to restore fluid levels and vitamins, electrolytes, minerals, amino acids and other nutrients directly to the bloodstream, increasing energy, boosting health, cleansing and hydrating instantly. IV DRIPS Customized IV Hydration & Wellness also offers focused drip formulas for prenatal, migraines, food poisoning, detox, vitality and a specialized NAD+ infusion, which can improve health down to the cellular level. During an appointment, a nurse will come to a client’s residence or location to complete the treatment. The qualified staff at IV DRIPS are trained to medically evaluate clients before starting and provide painless, effective IV drip therapy, which typically takes only 30-45 minutes. When a body or brain boost is necessary, IV therapy drips and infusions in Sacramento, CA, are now just a call away, bringing clients direct, customized IV therapy.

Brandon Weening joins Lime Connect Canada Board of Directors


OMERS, one of Canada’s largest defined benefit pension plans, and its real estate arm, Oxford Properties, began its partnership with Lime in 2023, supporting talent acquisition through recruitment and networking events. OMERS also partners with Lime for events and other forums that provide education opportunities for those working in the disability talent space. As an organization, OMERS recognizes that diverse talents drive business forward and is dedicated to empowering employees who want to make an impact.

Andrew Masson, Senior Director of Corporate HR at Rogers Communications, and president of Lime Connect Canada’s Board of Directors, says, “Brandon is a highly respected business professional, and his leadership and strategic focus are assets to Lime Connect Canada’s work throughout the provinces. We are proud to welcome him to the Board, and are excited to partner to highlight the importance, and incredible value, of the broad talent pool of people with disabilities as a result.”

Weening, speaking of his role with Lime Connect, said, “At OMERS we are building tomorrow together – which requires that we foster a culture where everyone can reach their full potential. As someone with a non-visible disability, I know how meaningful it is to work for organizations, like OMERS, that recognize and value each person’s diverse strengths and talents. This is why I’m proud to join Lime Connect Canada, and to support its mission — breaking stereotypes and leading employers to empower professionals with disabilities.”

About Lime Connect
Lime Connect is a not-for-profit organization that is rebranding disability through achievement – with the largest network of high-potential university students and professionals with disabilities (including veterans) in the world. Lime attracts, prepares, and connects disabled individuals for scholarships, leadership programs, internships, and full-time careers with our partners — the world’s leading corporations. This work showcases the vast strengths and talents that are found in disabilities, and provides individuals with tools, self-confidence, community, and connections to realize their dreams.

Lime Connect developed The Lime Community in 2023 as the go-to resource for talent, education, and community in the disability talent space. All individuals with an interest are encouraged to join, and engage, as People with Disabilities (Lime Network members’ private community), or the broader communities of Friends of Lime (allies), university partners, and corporate partners.
Learn more, and join us, at http://www.limeconnect.com.

Media Contact

Susan Lang, Lime Connect, (212) 521-4469, [email protected], www.limeconnect.com

Twitter Facebook

SOURCE Lime Connect



Creators Entertainment Group Celebrates Transformative Brand Partnerships, Achieving Remarkable Results, Exceptional Performance, and Unparalleled Growth Capabilities.


Creators Entertainment Group (CEG), The Creative Agency of the Future, is setting a new standard in healthcare marketing partnerships.

NEW YORK, Dec. 4, 2023 /PRNewswire-PRWeb/ — Creators Entertainment Group (CEG), The Creative Agency of the Future, is setting a new standard in healthcare marketing partnerships. As a trailblazer in the influencer marketing industry, CEG is redefining brand collaborations aimed at making a positive impact on lives.

CEG goes beyond conventional influencer marketing by designing and executing influencer-powered brand partnership campaigns for social good. One notable example is the collaboration between Eli Lilly and Hip Hop Artist Rob Base. Together, they unveiled an impactful campaign focused on raising awareness and educating healthcare professionals and adults about kidney disease. Base’s iconic 1998 hit song “It Takes Two” was re-recorded to emphasize the importance of comprehensive kidney testing through blood and urine samples. Rob Base, now 56 and having experienced the loss of his friend and musical partner, urges proactive health checks.

In another impactful healthcare partnership, CEG collaborated with Jovi, a brand dedicated to freeing women from pain with an innovative, reusable pain relief patch. To honor and support Breast Cancer Awareness Month, Jovi created a special pink patch for those who are currently or have previously suffered from Breast Cancer. Jovi’s BCA campaign and the pink patch created for post-mastectomy relief were a phenomenal success. For every patch sold, Jovi generously donated a product to breast cancer patients, resulting in a sold-out campaign and widespread acclaim.

CEG is making a resolute commitment to healthcare by fostering brand partnerships that make a meaningful impact and drive success through authentic talent promotion. With an unwavering dedication to excellence and innovation, CEG values impactful partnerships that contribute to the betterment of society and support the ongoing growth and prosperity of its partners.

About Creators Entertainment Group:

Creators Entertainment Group (CEG) has been the leading creator agency in the country for the last 25 years. At CEG, we infuse authenticity, transparency, and genuineness into campaign strategies for targeted growth through brand partnerships and creator collaborations. For more information, visit www.cegtalent.com

Media Contact

Toni Mattia, Creators Entertainment Group, 1 (212) 921-2190, [email protected]

SOURCE Creators Entertainment Group

Paris Baguette Continues To Dominate the Bakery Franchise Industry, Signs Agreement in Roseville, MN for One Location


With 109 freshly signed deals and over 40% year-over-year growth, Entrepreneur Magazine’s No. 1 bakery/cafe brand is poised to meet, if not exceed, its goal of 64 units opened in 2023, expanding to Florida, Hawaii, Maryland and more.

ROSEVILLE, Minn., Dec. 4, 2023 /PRNewswire-PRWeb/ — Paris Baguette, the bakery café concept with 4,000 units worldwide including nearly 150 in the United States, has seen significant growth in the past year. After a remarkable 2022 and strong end of 2023, the franchisor is continuing along an impressive growth trajectory with its most recent signing in Roseville, MN.

“We are thrilled to announce additional expansion within Minnesota. There’s a tremendous amount of opportunity in the bakery café space,” explained Eric Lavinder, Chief Development Officer. “No other bakery café franchisors are doing what Paris Baguette is on the same scale. Our ability to stay true to our bakery café roots while embracing aggressive expansion has garnered attention, and that only serves to drive us forward.”

The Roseville deal will bring the total number of locations within Minnesota to one. The agreement was signed by Wendy Yang & Hongkong Vang who are pioneering the additional growth.

“When looking for the right franchise opportunity, Paris Baguette was the ideal fit because of its amazing product line, store design and proven response from communities throughout the United States,” said Yang.

Moving forward, the brand continues to eye the 1,000 unit mark within the U.S. by 2030, and as it continues to grow, Lavinder explained that Paris Baguette seeks passionate franchisees interested in serving people in a welcoming neighborhood establishment.

“We want someone who is going to take the time to put the right staff members in place in their store and ensure everyone understands the most important person is the guest,” he added.

Within the $17 billion bakery segment, Paris Baguette continues to differentiate itself by offering breads, cakes and pastries made fresh daily, unlike many other concepts that primarily offer soups, salads and other pre-made goods.

For franchisees looking to break into the industry, Paris Baguette provides remarkable brand recognition, unique guest offerings and strong franchisee support while maintaining its commitment to following a true bakery café model.

In 2023, Paris Baguette aims to sign 160 franchise agreements and open 64 new cafés. Lavinder said target markets for the coming year include Washington, California, Arizona, Colorado, Minnesota, Kansas, Oklahoma, Texas, Missouri, Wisconsin, Illinois, Tennessee, Georgia, Florida, North Carolina, South Carolina, Kentucky, West Virginia, Virginia, Ohio, Indiana, Michigan, Pennsylvania and Maryland. He added that the brand will continue its development in New Jersey and New York and expand in some additional states in New England, including Connecticut and Massachusetts.

“We are on track to enter 45 new markets and open a total of 64 units by the end of 2023,” said TJ Rogers, franchise sales manager. “Even throughout the pandemic and its aftershocks, we did not shy away from opening additional units and exploring new markets. With great year-over-year revenue increases and a persistent interest in the brand from franchisees and consumers alike, we expect nothing but a strong continued growth trajectory for the brand.”

The total investment to franchise with Paris Baguette ranges from $652,565 and $1,750,900 including a $50,000 franchise fee. For more information, please visit https://parisbaguette.com/franchising/.

ABOUT PARIS BAGUETTE
Paris Baguette is a bakery café franchise with more than 4,000 units across the globe. The global brand first franchised in the U.S. in 2015 and has since established nearly 150 locations in markets across the country, making it one of the premier franchise opportunities in its category. Paris Baguette’s primary mission, executed every day by its expert staff of bakers, cakers and baristas, is to share moments of joy with guests and help guests share moments of joy with their friends and family by providing world-class cakes, pastries, coffees, breads and other French-inspired bakery café fare. To find out more information on costs to buy this franchise, please visit https://ownaparisbaguette.com/.

Media Contact

Julie Maw, Mainland, 3125263996, [email protected], www.hellomainland.com

SOURCE Paris Baguette

Alucio™ Unveils Beacon Hub 2.0 to Further Elevate HCP and Stakeholder Engagement


These improvements include the ability for MSLs to highlight key sections of the content that they have uploaded to Beacon Hub. This in turn activates automated pointers or bookmarks for HCPs, enabling them to jump directly to those highlighted content sections without having to wade through entire documents.

In addition, there are now new collaboration capabilities designed for Medical Communications Teams to create shareable Hubs around disease areas, congress meetings, or important educational initiatives and then publish those Hubs to MSLs for approved external distribution. This capability can also be very helpful for Medical Information teams wanting to disseminate critical product-related content packets in a real-time manner.

Furthermore, within Beacon Hub, designated HCPs now have the capability to upload their own documents, such as presentation slides or research reports, and share additional resources like journal article links or social media posts with MSLs and life science companies. This secure feature fosters additional collaboration and information exchanges between HCPs and the company on key scientific topics or research.

All of these new enhancements in Beacon Hub are fully customizable and configurable according to individual customer business needs and compliance guidelines.

“We are committed to delivering cutting-edge engagement and collaboration capabilities to provide meaningful benefits to our Beacon customers,” shared Eric Chen, Alucio’s Chief Technology Officer. “With this enhanced release of Beacon Hub, field users will be able to conduct deeper and extended scientific exchanges with the KOLs they are interacting with.”

“It is really exciting to see these meaningful, new enhancements in Beacon Hub as part of the broader Beacon platform,” echoed Nika Sajed, Principal Medical Scientist at Gilead. “In field medical, we are always looking for creative ways to extend the scientific conversation with HCPs. Beacon Hub is a very unique and flexible solution that allows MSLs and Medical Affairs teams to respond to stakeholder needs, increase connectivity and deepen relationships.”

About Alucio:
Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at [email protected] (925) 788-3533.

Media Contact

Lisa Amin, Alucio, 925-788-3533, [email protected], https://www.alucio.io

SOURCE Alucio

Wendy Webber Nelson, PhD and Michael Patsalos-Fox Join SciShield’s Board of Directors


Industry Luminaries Bring Expertise and Leadership

SAN FRANCISCO, Dec. 4, 2023 /PRNewswire-PRWeb/ — SciShield, a leading provider of safety and regulatory compliance management software for scientific laboratories, today announced that Wendy Webber Nelson, PhD and Michael Patsalos-Fox have joined its Board of Directors. Both bring decades of experience in corporate leadership and the life sciences industry.

“I am excited to welcome Dr. Wendy Webber Nelson and Michael Patsalos-Fox to the SciShield Board of Directors. Wendy and Michael bring a depth of expertise and customer focus that’s truly inspiring, said Nathan Watson, Founder & CEO of SciShield. “I’m looking forward to collaborating with them to enrich our strategic initiatives and deliver even more scientific innovation to our customers.”

Wendy is the President and Founder of the Boston Biotech Forum, an executive networking group created in 2011 to address pertinent industry topics with executive leaders and technical experts that has expanded to include over 300 leading biopharma companies around the world. Additionally, Wendy serves as the Chief Business Officer for Danforth Advisors, acts as an advisor for Dreavent Capital and Modern Vivo, and is a Venture Partner at Waterman Ventures. Previously, Wendy was CEO of LeadingBiotech, held senior business development or operational roles at Frontage Laboratories, inVentiv, Worldwide Clinical Trials, QPS, Alantos Pharmaceuticals, and Alkermes. Wendy is also an inventor on multiple patents and the senior author of numerous scientific publications.

“I am thrilled to join the SciShield team and expand usage of its laboratory safety compliance and sample inventory management tools in our industry at a time when efficient use of capital is critical, ” said Wendy Webber Nelson.

Michael is the Chair of MIO Partners and serves on the board of directors for Cognizant. He is the former Chairman of the Board and CEO of Vidyo, Inc., a video telehealth platform provider. Previously, Michael was the CEO of Stroz Friedberg, Inc., a global cybersecurity firm and was a Senior Partner at McKinsey & Company where he worked for 32 years. During his tenure at McKinsey, Michael served on the Board of Directors for 12 years, served on the firm’s Operating Committee, and led the Americas Region, the New York and New Jersey offices, the North American Corporate Finance and Strategy practice and the European Telecoms practice.

“I am excited to be working with Nathan and the team to grow SciShield as it becomes ever more critical to the safe, orderly and high integrity in management of lab resources, especially in the new world of environmental awareness and regulation”, said Michael Patsolos-Fox.

“We’re thrilled to welcome Wendy and Michael to the SciShield Board of Directors,” said Neil Willis, member of the SciShield Board of Directors and Partner at Strattam Capital. “Their commitment to excellence aligns seamlessly with SciShield’s unwavering dedication to improving the health, safety and efficiency of scientists everywhere and we look forward to their contributions.”

About SciShield

SciShield reduces burden on scientists worldwide while increasing safety, regulatory compliance, and operational efficiency for their organizations through our modular, enterprise software solutions. SciShield’s customers range from biotechs and life science incubators to over a third of the top-tier (R1) research institutions, and top-10 pharmaceutical companies. Free your scientists from the burden with SciShield.com.

Media Contact

Kimberley Kasper, Strattam Capital, 1 4152302705, [email protected], Strattam Capital

SOURCE SciShield

RT MicroDx Founder & CEO Nathalya Mamane to Present at New England Venture Summit


RT MicroDx is working to develop a platform technology to bring molecular diagnostics for common infectious diseases into consumers’ homes. As a first use case, Mamane and her team have selected the use of saliva and the detection of Strep A infection; they are planning to develop similar home diagnostic tests for RSV, mononucleosis, meningococcal disease, staphylococcus, haemophilus influenzae, and more in the future. Previous studies (not conducted by RT MicroDx) have proven that saliva is an adequate vector for detecting strep using DNA amplification, and RT MicroDx has developed a patented, first-of-its-kind technology that, if approved, will allow for a simple, binary, positive/negative strip readout without the need for expensive laboratory equipment, advanced health literacy, or access to technology to interpret results at home.

“Current molecular diagnostic tests are either lab tests that require taking time off work, getting a doctor appointment, and traveling to the doctor’s office – not to mention the high costs of health insurance and copays – or they are at-home tests (for COVID-19 and flu only) that are cost prohibitive. And for Strep A, there are no at-home tests at all,” Mamane explained. “This just isn’t sustainable. We need diagnostic options that are accessible for everyone. We need a better way.”

RT MicroDx has completed proof-of-concept studies for its Strep A test and is currently seeking capital in order to submit for FDA approval to begin first-in-human trials. The company has previously earned recognition as a runner-up in the 2022 MIT Launch Challenge, first place winner in the Blank Center for Entrepreneurship at Babson College “Babson Entrepreneurial Thought & Action” challenge, a finalist in the Mass Challenge US Early Stage Cohort 2022, and a finalist in the Mass Innovation Eddies Cohort 2023. Mamane and RT MicroDx have also been featured in Axios, GenomeWeb, and Boston Business Journal.

RT MicroDx’s technology and diagnostic tests are in prototype stage and have not been evaluated or approved by the FDA.

To schedule a meeting with Mamane at the New England Venture Summit, email: [email protected].

About RT MicroDx

RT MicroDx is a biotech company working to develop a technology platform for affordable, accurate, at-home molecular diagnostics for common infectious diseases. We are a woman-owned, minority-owned business, driven by our passion to make diagnostics affordable and accessible to all. High costs of healthcare, social determinants of health, economic disparities, and physician shortages have combined to form the perfect storm to make our current way of delivering healthcare in the US unsustainable. We’re working to find a better way. To learn more, visit https://rtmicrodx.com/.

Media Contact

Jennifer Ringler, RT MicroDx, 1 973-647-5004, [email protected], https://rtmicrodx.com/ 

SOURCE RT MicroDx

Frazier & Deeter Recognized as Best Firm for Equity in Leadership


“At FD, we are committed to our team’s development. Through comprehensive training, dedicated mentoring and flexible workplace initiatives, we’ve fostered an environment where talent thrives. Notably, 35% of our partners and principals are women, and we are excited about further cultivating an environment where all team members, regardless of level, can realize their full potential both personally and professionally,” noted Seth McDaniel, FD Managing Partner.

FD has fostered a resilient culture that centers on growth and uplifts employees, clients and its local communities. To fortify this base, the firm continues to prioritize Diversity, Equity & Inclusion (DEI) efforts that educate, encourage and pave the way for fair opportunities.

“As Chair of the Board, I am thrilled that FD has once again been recognized as a Best Firm for Equity Leadership,” said LeighAnn Costley, FD Partner and Chair of the Board of Directors. “We have experienced substantial growth in revenue, employee headcount and number of partners over the past ten years and have consistently maintained our commitment to diversity in leadership throughout that time. As we look to the future, we will continue to build on this success by focusing on our brand promise to invest in relationships together to make an impactful difference for our people and clients.”

Since 2010, the Accounting MOVE Project has been dedicated to assessing and promoting the progress of women in accounting and consulting firms. It stands out as the sole annual benchmarking initiative that not only quantifies but also advocates for the advancement of women in the profession.

“When options abound, women want to work for firms that appreciate their talents and give them opportunities to advance at a pace that fits with the rest of their lives. That’s why programs like the Accounting MOVE Project are so important to identify firms that have a history of women in leadership and offer flexible career options,” said Cindy Stanley, Executive Director of the Accounting and Financial Women’s Alliance.

About Frazier & Deeter
Frazier & Deeter is an award-winning Top 50 accounting and advisory firm that offers a full scope of tax, audit, internal controls advisory and business transformation services. FD and its family of brands serve clients worldwide, from the Fortune Global 500 companies to growing small businesses, and the firm has been recognized repeatedly as a Best of the Best Accounting firm, a Best Firm to Work For® and a Best Firm for Women in Leadership.

About the Accounting MOVE Project
The Accounting MOVE Project is based on the MOVE methodology, developed by research partner Wilson-Taylor Associates, Inc., which investigates the factors proven to be essential to women’s career success:
M – Money: fair pay practices;
O – Opportunity: advancement and leadership development;
V – Vital supports: work-life programs that remove barriers;
E – Entrepreneurship: operating experience for managing or business ownership
The MOVE Project advisory board includes leaders from association partner the Accounting and Financial Women’s Alliance, founding sponsor Moss Adams and supporting sponsor SAPRO. See the archives of MOVE Project reports at https://accountingmoveproject.com/archives/. 

Media Contact

Katelyn Brown, Frazier & Deeter, 770.880.0372, [email protected], https://www.frazierdeeter.com/

SOURCE Frazier & Deeter

Xtalks Announces its Life Science Webinar Calendar for December 2023


Upcoming free, educational webinars from Xtalks will feature topics on cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, fundamental research, healthcare, laboratory technology, medical device, patient recruitment & retention, pharma manufacturing & supply chain and preclinical.

TORONTO, Dec. 4, 2023 /PRNewswire-PRWeb/ — Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Visit http://www.xtalks.com to see our upcoming webinars:

CELL AND GENE THERAPY
December 1– Adoptive Cell Therapy in Oncology: Key Considerations and Developments

CLINICAL TRIALS
December 4– Clario’s Oncology Webinar Series
December 4– Unlocking Dry Eye Innovation with The Latest Clinical Designs and Technologies
December 4– Three Key Strategies to an Optimal Functional Service Provider (FSP) Partnership
December 5– Easing the Challenges of Global Feasibility: Strategies to Balance Priorities, Manage Disparate Data Sources and Mitigate Risk
December 6– See How it’s Done: Case Studies on Patient Experience Design
December 7– Amplifying Evidence with Unified Clinical Trial Data Collection
December 8– Endpoints for Neuroprotection in Glaucoma Trials
December 11– Navigating Industry Needs for Retina Therapy Clinical Research Success
December 12– Are Regulators Driving or Impeding Innovation in Clinical Trials?
December 18– How to Accelerate Lupus Solutions with RWD
December 19- 10 Things You Didn’t Know About Decentralized Clinical Trials

COMMERCIALIZATION & HEOR
December 11– From Vanity Metrics to Valuable Insights: Unveil Your Marketing Impact

DRUG DISCOVERY & DEVELOPMENT
December 5– Powering the AI Revolution for Drug Discovery with High-Quality Empirical Data
December 6– The Impact of GLP-1s on Cardiovascular Clinical Development
December 6– Digital Strategies to Accelerate Modern Biopharmaceutical Process Development
December 7– FDA Oncology Center of Excellence: Programs & Projects That Impact Drug Development
December 18– Inhaled Biologics: Formulation, Analysis and Regulation
December 18– Vaccine Clinical Development: Key Ingredients to Improve Efficiency

FUNDAMENTAL RESEARCH
December 1– Psychedelics 3.0: Challenges and Opportunities in a Rapidly Evolving Field
December 8– Strategies to Prevent Contamination in a Cell Culture Lab
December 13– Artificial Intelligence in Chemistry: Opportunities, Trends and Challenges

HEALTHCARE
December 1– Holistic Measures of Physical Functioning in Cancer: New Opportunities with Digital Health Technologies
December 4– Personalizing Healthcare with Digital Technologies

LABORATORY TECHNOLOGY
December 8– Bispecific Antibodies: Structural Design, Production and Purification Strategies
December 11– A Rapid Single Cell Cloning Workflow for Antibody Discovery from Rabbits: A Case Study
December 18– Breast Cancer Multiomics: Unified Insights in Tumor Heterogeneity

MEDICAL DEVICE
December 6– Navigating SaMD and SiMD: Real-World FDA Regulatory Strategies for Medical Device Software

PATIENT RECRUITMENT & RETENTION
December 5– New Approaches to Adherence and Prevention of Dropouts: The Digital Era of Patient Engagement

PHARMA MANUFACTURING & SUPPLY CHAIN
December 5– Warehouse Automation Within the Pharmaceutical Industry: Logistics from Dock to Dock
December 14– Ahead of the Curve: Formula for Pharmaceutical Logistics and Supply Chain Success in 2024
December 14– Unleashing the Potential of ADCs with High-Quality Bioreagents

PRECLINICAL
December 12– Risk Assessment of Novel Neurotherapeutics: Mechanistic Translation of Preclinical Safety and PK/PD Data to a Clinical Setting

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com. 

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected]

SOURCE Xtalks